Major shareholder Braden Michael Leonard purchased 528,621 Aclaris Therapeutics shares on June 13th, increasing his total holdings.
Major shareholder Braden Michael Leonard bought 528,621 Aclaris Therapeutics shares on June 13th for $607,914.15 at an average of $1.15 per share, increasing his total holdings to 11,007,134 shares worth $12,658,204.10. Aclaris Therapeutics reported a negative ROE of 61.03% and net margin of 248.28% in its last quarterly earnings. StockNews.com downgraded Aclaris shares from "hold" to "sell" in April.
June 16, 2024
3 Articles